WVE Earnings

WVE reported its FY2025Q3 earnings on 2025-11-10, showcasing a revenue of 8.00M against an estimate of 11.00M, resulting in a -27.73% surprise. The EPS was -0.32, surpassing the expected -0.3 by -6.67% . The stock experienced a -10.31% price change on the earnings day and a -15.14% change over the next five days, reflecting market reactions to the results.

Following WVE's FY2025Q3 earnings announcement on 2025-11-10, the stock price moved by -10.31% on the day of the release. Over the subsequent five days, it saw a -15.14% change. Historically, WVE's stock price tends to shift by an average of -3.28% in the 10 days leading up to earnings and -2.02% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate WVE’s annual revenue to reach 17.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Revise Downward by -10.6% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between WVE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Revise Downward by -10.6% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, WVE's stock price typically moves by -3.28% in the 10 days before its earnings and -2.02% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 17.00M.

The earnings call summary indicates a mix of positive and cautious elements. While there are promising developments in product pipelines and strategic plans, there are also uncertainties, particularly in the obesity program and AATD study. The Q&A highlighted management's avoidance of specifics, which may raise concerns. No strong catalysts like partnerships or record revenues were mentioned, and the strategic plan lacks immediate financial impact. The absence of market cap data limits assessment of stock sensitivity, but overall sentiment leans towards neutral given the balanced positives and uncertainties.